2-Year survival benefit from immunotherapy for squamous cell cancer with cancer of unknown primary in mediastinum: a case report

Overview of attention for article published in Frontiers in oncology, October 2023

Altmetric Badge

Mentioned by

twitter: 2 X users

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 18,663 followers.

RT @FrontOncology: New research: 2-Year survival benefit from immunotherapy for squamous cell cancer with cancer of unknown primary in medi…

15 Oct 2023

Reply Repost Favourite

New research: 2-Year survival benefit from immunotherapy for squamous cell cancer with cancer of unknown primary in mediastinum: a case report: Cancers of unknown primary (CUP) account for 2%–5% of all diagnosed cancers and are always… https://t.co/uP3Nrku

14 Oct 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.